Triptans for migraine management in adolescents

Headache

Volumn 42, Issue 7, 2002, Pages 675-679

  Winner, Paul ^a,b  

^a Palm Beach Headache Center   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

Adolescents; Headache relief; Migraine; Sumatriptan; Triptans

Indexed keywords

ANTIMIGRAINE AGENT; PLACEBO; TRIPTAN; UNCLASSIFIED DRUG;

ADOLESCENCE; AGE; CLINICAL FEATURE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERANCE; HEADACHE; HUMAN; MEDICAL RESEARCH; META ANALYSIS; MIGRAINE; PRIORITY JOURNAL; REVIEW; TIME;

ADOLESCENT; HUMANS; MIGRAINE DISORDERS; SEROTONIN AGONISTS;

EID: 0036656638     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.2002.02157.x     Document Type: Review

References (27)

1. Prevalence of headache and migraine in school children
2. An epidemiological study of headache among children and adolescents of southern Brazil
3. The prevalence of headache in migraine in atopic children: An epidemiological study in general practice
4. Definitions, clinical features, and diagnosis of migraine
5. Migraine in school children
6. Headache in children and adolescents
7. Diagnosis of headache in children and adolescence: A study in 437 patients
8. Effect of age on the fulfillment of the IHS criteria for migraine in children at a headache clinic
9. Classification of pediatric migraine: Proposed revisions to the IHS Criteria
10. An epidemiologic study of headache among adolescents and young adults
11. Headaches in adolescents. Diagnosis and management
12. Appropriate migraine therapy for children and adolescents
13. Migraine in children: Guidelines for treatment
14. Pediatric headaches: What's new?
15. Migraine
16. Demographic and migraine characteristics of adolescent patients: The Glaxo Wellcome Clinical Trials Database
17. A randomized, double-blind, placebo-controlled study of sumatriptan nasal spray in the treatment of acute migraine in adolescents
18. Clinical profile of rizatriptan 5 mg in adolescent migraineurs
19. Clinical profile of rizatriptan 5 mg in adolescent migraineurs
20. Efficacy, safety, and tolerability of oral eletriptan (40 mg) for the treatment of acute migraine in adolescent (12-17 years)
21. An investigation of the placebo effect and age-related factors in the report of needle pain form venipuncture in children
22. The importance of placebo effects in pain treatment and research
23. The placebo problem in child and adolescent psychiatry
24. Long-term tolerability of sumatriptan nasal spray for adolescent migraine: Results of an open-label study
25. Zolmitriptan provides effective migraine relief in adolescents
26. Treatment of mild pain with sumatriptan in the spectrum of headache patients with disabling IHS migraine
27. Treatment of mild headache in disabled migraine sufferers: Results of the Spectrum Study